The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Callicutt Jack W since 2018.
This trader's CIK number is 1266773.
At the time of last reporting, Callicutt Jack W was the Chief Financial Officer of Galectin Therapeutics Inc. (stock ticker symbol GALT).
Also see all insider trading activities at Galectin Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | GALT | 0 | $0 | 8,706 | $56,057 | 8,706 | $11,927 |
| 2022 | GALT | 4,000 | $5,280 | 0 | $0 | 0 | $0 |
| 2019 | GALT | 2,354 | $10,075 | 0 | $0 | 0 | $0 |
| 2018 | GALT | 0 | $0 | 405,294 | $2,963,696 | 405,294 | $1,105,498 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-12 | GALT | Option Ex | 8,706 | 1.37 | 11,927 |
| 2025-09-12 | GALT | Sale | 8,706 | 6.44 | 56,057 |
| 2022-11-17 | GALT | Buy | 4,000 | 1.32 | 5,280 |
| 2019-05-31 | GALT | Buy | 2,354 | 4.28 | 10,075 |
| 2018-06-19 | GALT | Option Ex | 128,733 | 3.93 | 505,920 |
| 2018-06-20 | GALT | Option Ex | 97,267 | 4.41 | 428,947 |
| 2018-06-19 | GALT | Sale | 128,733 | 9.01 | 1,160,013 |
| 2018-06-20 | GALT | Sale | 97,267 | 8.08 | 786,014 |
| 2018-06-12 | GALT | Sale | 9,294 | 7.01 | 65,169 |
| 2018-06-12 | GALT | Option Ex | 9,294 | 1.37 | 12,732 |
| 2018-06-08 | GALT | Option Ex | 100,000 | .87 | 87,000 |
| 2018-06-08 | GALT | Sale | 100,000 | 5.75 | 575,000 |
| 2018-06-11 | GALT | Option Ex | 20,000 | 1.37 | 27,400 |
| 2018-06-11 | GALT | Sale | 20,000 | 6.38 | 127,500 |
| 2018-05-31 | GALT | Option Ex | 46,651 | .87 | 40,586 |
| 2018-05-31 | GALT | Sale | 46,651 | 5.00 | 233,255 |
| 2018-04-04 | GALT | Option Ex | 3,349 | .87 | 2,913 |
| 2018-04-04 | GALT | Sale | 3,349 | 5.00 | 16,745 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Callicutt Jack W (Chief Financial Officer of Galectin Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.